João Siffert compensation by year
ABEONA THERAPEUTICS Summary Compensation Table · all 2 fiscal years held| Component | FY2018 | FY2019 |
|---|---|---|
| Salary | $104,295 | $550,000 |
| Bonus | $45,818 | $206,250 |
| Stock awards | $0 | $0 |
| Option awards | $1,313,990 | $1,463,611 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $95,000 | $106,200 |
| Total | $1,559,103 | $2,326,061 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ABEONA THERAPEUTICS INC. DEF 14A filed April 9, 2021, accession 0001140361-21-012309, and prior-year filings. Open the filing on EDGAR.
How this page was built: the ABEONA THERAPEUTICS INC. filed document, accession 0001140361-21-012309. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2021.
Equity holdings
unvested awards at FY2019 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 127,500 | — | $9.23 |
| Option | 100,000 | — | $7.24 |
| Option | 110,000 | — | $6.70 |
| Option | 60,000 | — | $6.59 |
Per the Outstanding Equity Awards at Fiscal Year-End table in ABEONA THERAPEUTICS INC.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.
ABEONA THERAPEUTICS’s named executive officers, FY2019
as the company reported each| Named executive officer | Role | FY2019 total |
|---|---|---|
| João Siffert · this page | Former Chief Executive Officer, Head of Research & Development and Chief Medical Officer | $2,326,061 |
| Steven Rouhandeh | Former Executive Chairman | $1,480,019 |
| Christine Silverstein | Former Chief Financial Officer | $1,000,225 |
The full ABEONA THERAPEUTICS compensation record
free company briefThis page is one person within ABEONA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ABEONA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.